Robot Removes Kidney Tumors on Its Own in Lab Test
Robot surgeons that adapt mid-operation could mean more precise cancer surgery for you.
A team of surgeons and engineers has built what it calls the first robot able to perform a complete kidney tumor removal without a human holding the tools. In a study posted online, the machine handled every step: finding the tumor, planning the cuts, and slicing it out. Kidney-sparing surgery like this is delicate — remove too little and cancer stays behind, remove too much and the patient loses healthy kidney function.
What makes it work is software called an occupancy network. Think of it as the robot's imagination: from a single camera angle, it builds a full 3D map of what is where — tumor, healthy kidney, safety margin. Crucially, it keeps updating that map even as tissue gets cut and shifts, something earlier systems could not do. They could only work on the surface of organs, not inside soft tissue that moves.
The hardware is a depth camera plus two robotic arms — one for cutting with electrical current, one for holding tissue with suction. In tests on hydrogel phantoms (lab-made stand-ins shaped like real kidneys from patient scans), the robot completed eight tumor removals in a row, making 77 cuts. Every single cut had a "negative margin," meaning no cancer cells at the edge, and the average error on margin distance was 1.61 millimeters — roughly the thickness of a dime.
The catch is big: this was hydrogel, not living human tissue, and the setup was open surgery rather than the keyhole procedures most patients get. A human still supervised throughout. The authors call it a foundation for supervised autonomy — a first step, not a finished product. Real operating rooms are years away, but the direction is clear: machines that see, adjust, and cut more steadily than a tired human hand.
- A research robot removed kidney tumors completely by itself — a first for soft, shifting tissue that changes shape as it is cut.
- It made 77 cuts across eight test runs, and every cut left clean edges around the cancer, with average error about the thickness of a dime.
- This happened on lab-made stand-ins for kidneys, not real patients, and a human surgeon supervised the whole time.
Why It Matters
More precise tumor removal could mean fewer repeat surgeries, less healthy tissue lost, and steadier results for cancer patients.